MARWITZ, Sebastian, TURKOWSKI, Kati, NITSCHKOWSKI, Dörte, WEIGERT, Andreas, BRANDENBURG, Julius, REILING, Norbert, THOMAS, Michael, RECK, Martin, DRÖMANN, Daniel, SEEGER, Werner, RABE, Klaus F., SAVAI, Rajkumar und GOLDMANN, Torsten, [no date]. The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC. Frontiers in oncology. No. Band 9 (2020), Artikel-ID: 1550, p. , Artikel-ID: 1550. DOI 10.3389/fonc.2019.01550.
Elsevier - Harvard (with titles)Marwitz, S., Turkowski, K., Nitschkowski, D., Weigert, A., Brandenburg, J., Reiling, N., Thomas, M., Reck, M., Drömann, D., Seeger, W., Rabe, K.F., Savai, R., Goldmann, T., o. J. The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC. Frontiers in oncology , Artikel-ID: 1550. https://doi.org/10.3389/fonc.2019.01550
American Psychological Association 7th editionMarwitz, S., Turkowski, K., Nitschkowski, D., Weigert, A., Brandenburg, J., Reiling, N., Thomas, M., Reck, M., Drömann, D., Seeger, W., Rabe, K. F., Savai, R., & Goldmann, T. (o. J.). The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC [Electronic]. Frontiers in oncology, Band 9 (2020), Artikel-ID: 1550, , Artikel-ID: 1550. https://doi.org/10.3389/fonc.2019.01550
Springer - Basic (author-date)Marwitz S, Turkowski K, Nitschkowski D, Weigert A, Brandenburg J, Reiling N, Thomas M, Reck M, Drömann D, Seeger W, Rabe KF, Savai R, Goldmann T The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC. Frontiers in oncology , Artikel-ID: 1550. https://doi.org/10.3389/fonc.2019.01550
Juristische Zitierweise (Stüber) (Deutsch)Marwitz, Sebastian/ Turkowski, Kati/ Nitschkowski, Dörte/ Weigert, Andreas/ Brandenburg, Julius/ Reiling, Norbert/ Thomas, Michael/ Reck, Martin/ Drömann, Daniel/ Seeger, Werner/ Rabe, Klaus F./ Savai, Rajkumar/ Goldmann, Torsten, The multi-modal effect of the anti-fibrotic drug pirfenidone on NSCLC, Frontiers in oncology , , Artikel-ID: 1550.